Biochemical analysis showed that compared to the HF group, ginsenoside Rb1 administration significantly inhibited the abnormal increase in ANP and BNP levels (p < 0.05 or p < 0.01 or p < 0.001) (Figure 2B). The gene discussed is NPPA; the disease is hydrops fetalis.